Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Injection that boosts white cell recovery after chemotherapy. | Rescue and booster medicine used with methotrexate and fluorouracil. |
| Body system | Cancer | Cancer |
| Drug class | Blood cell growth factors | Chemotherapy rescue agents |
| Supply | Prescription onlyWHO essential medicine | Prescription onlyWHO essential medicine |
| Main uses | Chemotherapy-induced neutropenia, Stem cell mobilisation, Severe chronic neutropenia | Methotrexate rescue, Colorectal cancer (with fluorouracil), Megaloblastic anaemia (rarely) |
| How it works | Speeds up white cell recovery. | Protects healthy cells from methotrexate and boosts fluorouracil. |
| Starts working | Depends on the cancer and regimen | Depends on the cancer and regimen |
| Half-life | About 3–4 hours | About 6 hours |
| Typical adult dose | Dosed by your cancer team according to the treatment protocol. | Dosed by your cancer team according to the treatment protocol. |
| Forms | Subcutaneous injection, IV infusion | IV injection, Tablet, Intramuscular injection |
| Common side effects | Bone pain, Headache, Injection site reactions | Nausea, Diarrhoea (with fluorouracil) |
| Serious side effects | Spleen rupture (rare), Lung inflammation, Sickle cell crisis | Allergic reaction (rare), Seizures if given into the spine |
| Don't take if | Allergy to filgrastim; Severe congenital neutropenia with leukaemia (caution) | Pernicious anaemia and B12 deficiency (can mask) |
| Alcohol | Usually no problem in moderation. No specific interaction. | Usually no problem in moderation. No specific interaction. |
| Pregnancy | Use with cautionLimited data; specialist decision. | Generally considered safeUsed when needed. |
| Breastfeeding | Use with cautionUnknown whether it passes into milk. | Generally considered safeConsidered acceptable. |
| In use since | — | — |
| Brand names | United States: Neupogen, Zarxio, NivestymUnited Kingdom: Neupogen, Zarzio, NivestimIndia: Grafeel, Neukine, Neupogen | United States: Leucovorin (generic), FusilevUnited Kingdom: Calcium folinate (generic)India: Leucovorin (generic), Folinic acid (generic) |
| Legal status | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM), hospital useIndia: Schedule H | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM), hospital useIndia: Schedule H |
| ATC code | L03AA02 | V03AF03 |
Taken together
No interaction between these medicines is recorded in the atlas.
Open in the interaction checker